Company: G
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001398659-25-000035
Chunk: 106

Company: Genpact LTD
Filing Date: 2025-03-03
Form: 10-K
Item: Item 7
Chunk 106
---
 31,Percentage change increase/ (decrease) 2024 vs. 202320232024(dollars in millions)Cash and cash equivalents$583.7 $648.2 11.1 %Short-term investments— 23.4 NM*Short-term borrowings10.0 — (100.0)%Long-term debt due within one year432.2 26.2 (93.9)%Long-term debt other than the current portion$824.7 $1,195.3 44.9 %Genpact Limited total shareholders’ equity$2,248.4 $2,389.6 6.3 %

*Not Meaningful

Financial Condition

We have historically financed our operations and our expansion, including acquisitions, with cash from operations and borrowing facilities.

As of December 31, 2024, $636.2 million of our $648.2 million in cash and cash equivalents was held by our non-Bermuda subsidiaries. $186.8 million of this cash is held by subsidiaries for which we expect to incur and have accrued a deferred tax liability on the repatriation of $117.5 million of retained earnings. $248.8 million of the cash and cash equivalents is held by foreign subsidiaries in jurisdictions where no tax is expected to be imposed upon repatriation. The remaining $200.6 million in cash and cash equivalents held by subsidiaries is being indefinitely reinvested.

On February 9, 2023, our board of directors approved a 10% increase in our quarterly cash dividend from $0.125 per common share to $0.1375 per common share, representing an annual dividend of $0.55 per common share for 2023, up from $0.50 per common share in 2022. On March 24, 2023, June 26, 2023, September 26, 2023 and December 22, 2023, we paid dividends of $0.1375 per share, amounting to $25.3 million, $25.0 million, $24.9 million and $24.8 million in the aggregate, to shareholders of record as of March 10, 2023, June 9, 2023, September 8, 2023, and December 8, 2023, respectively.

56

On February 8, 2024, our board of